FDA Inspection 1172058 — Ayman Gaballah, M.D.
The FDA completed an inspection of Ayman Gaballah, M.D. on Jun 10, 2022 in Columbia, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 10, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbia, MO (United States)
Additional Details
Clinical Investigator (CI)